 | | |
|
|
|
Wall Street darlings
Ranked by ratio of market value to revenue.
|
1 |
Oxigene |
$0.0 |
$81.8 |
11,686.3 |
|
2 |
Sontra Medical Corp. |
$0.0 |
$25.7 |
756.7 |
|
3 |
Ariad Pharmaceuticals |
$0.7 |
$295.8 |
398.7 |
|
4 |
Wave Systems Corp. |
$0.2 |
$73.1 |
349.9 |
|
5 |
Acusphere |
$1.7 |
$96.5 |
56.3 |
|
6 |
Medwave |
$0.9 |
$39.4 |
41.9 |
|
7 |
Curis |
$5.0 |
$171.4 |
34.6 |
|
8 |
NitroMed |
$16.5 |
$523.8 |
31.8 |
|
9 |
Oscient Pharmaceuticals |
$6.6 |
$178.7 |
27.0 |
|
10 |
EPIX Pharmaceuticals |
$12.3 |
$162.6 |
13.3 |
NOTE: Company stock must have been traded on Dec. 31, 2004, with a price of $1 a share or higher, and company must have a market value of $1 million or higher. SOURCE: Standard&Poor's Compustat
|
|
|
|
|
